-
Stock in News: Microsoft Corporation (NASDAQ:MSFT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Consolidated Communications Holdings Inc. (NASDAQ:CNSL), HEALTHSOUTH (NYSE:HLS), Piedmont Office Realty Trust (NYSE:PDM)
Microsoft Corporation (NASDAQ: MSFT) recently reported that users can now utilize the cryptocurrency Bitcoin to make purchases from the Windows, Windows Phone, Xbox Games, Xbox Music, and Xbox Video stores. Apart from what service has been reported by Microsoft, users will not be able to utilize the Bitcoin to buy other Microsoft services and products…
-
Trader’s Buzz: Microsoft Corporation (NASDAQ:MSFT), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), SWS Group (NYSE:SWS), ManpowerGroup Inc. (NYSE:MAN), 22nd Century Group (NYSEMKT:XXII)
Software developer Microsoft Corporation (NASDAQ:MSFT) recently announced that customers can now make payments for its digital products using Bitcoins. The service is currently available only in the United States. Microsoft Corporation (NASDAQ:MSFT) in last trading activity moved down -0.47% to close at $46.95. Company weekly performance is -3.04% while its quarterly performance stands at 2.18%.…
-
Active Stocks: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), El Paso Electric Co. (NYSE:EE), Canadian Natural Resources (NYSE:CNQ), GLNG
On 6 November Synta Pharmaceuticals Corp. (NASDAQ:SNTA) posted its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.24) by $0.05. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) in last trading activity increased 1.28% to close at $3.17. Company weekly performance is 2.59% while its quarterly performance…
-
Hot Watch List: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Zafgen (NASDAQ:ZFGN), Egalet Corporation (NASDAQ:EGLT), Gladstone Commercial Corp. (NASDAQ:GOOD), Air T Inc. (NASDAQ:AIRT)
On 6 November Synta Pharmaceuticals Corp. (NASDAQ:SNTA) posted its quarterly earnings results on Thursday. The company reported ($0.19) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.24) by $0.05. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) in last trading activity moved down -3.87% to close at $3.23. Company weekly performance is 5.08% while its quarterly…
-
Fast Moving Stocks: Crown Castle International Corp. (NYSE:CCI), Denbury Resources Inc. (NYSE:DNR), Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Ford Motor (NYSE:F), Sutron Corporation (NASDAQ:STRN)
Crown Castle International Corp. (NYSE:CCI) Director J Landis Martin acquired 60,000 shares of Crown Castle International Corp. stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average cost of $79.47 per share, with a total value of $4,768,200.00. Following the completion of the transaction, the director now directly…
-
Healthcare Top Losers- Galena Biopharma (NASDAQ:GALE), Agilent Technologies (NYSE:A), Synta Pharmaceuticals (NASDAQ:SNTA), Prana Biotechnology (NASDAQ:PRAN)
Galena Biopharma Inc. (NASDAQ:GALE)- A Lake Oswego biotech firm that saw its stock price more than triple since July has watched it plummet in recent days after company insiders — including directors and officers — made millions by selling hundreds of thousands of shares. Shares of Galena Biopharma Inc. (NASDAQ:GALE) closed at $3.73 in last…
-
Top Gainers Healthcare – BG Medicine (NASDAQ:BGMD), Cell Therapeutics (NASDAQ:CTIC), Synta Pharmaceuticals (NASDAQ:SNTA), Idera Pharmaceuticals (NASDAQ:IDRA)
BG Medicine, Inc. (NASDAQ:BGMD) skyrocketed 31.32% as the final determination of the 2014 Medicare national limitation amount for the company’s galectin-3 blood test at the amount of a crosswalked test whose 2014 national limitation amount is $30.01 was set to apply effective January 1, 2014. Moreover, the 2014 national limitation amount is subject to a…